Literature DB >> 3159976

Dopamine D2 receptors photolabeled by iodo-azido-clebopride.

H B Niznik, A Dumbrille-Ross, J H Guan, J L Neumeyer, P Seeman.   

Abstract

Iodo-azido-clebopride, a photoaffinity compound for dopamine D2 receptors, had high affinity for canine brain striatal dopamine D2 receptors with a dissociation constant (Kd) of 14 nM. Irradiation of striatal homogenate with iodo-azido-clebopride irreversibly inactivated 50% of dopamine D2 receptors at 20 nM (as indicated by subsequent [3H]spiperone binding). Dopamine agonists and antagonists prevented this photo-inactivation with the appropriate rank-order of potency. Striatal dopamine D1, serotonin (S2), alpha 1- and beta-adrenoceptors were not significantly inactivated following irradiation with iodo-azido-clebopride. Thus, iodo-azido-clebopride is a selective photoaffinity probe for dopamine D2 receptors, the radiolabelled form of which may aid in the molecular characterization of these proteins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159976     DOI: 10.1016/0304-3940(85)90446-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Developing Photoaffinity Probes for Dopamine Receptor D2 to Determine Targets of Parkinson's Disease Drugs.

Authors:  Spencer T Kim; Emma J Doukmak; Raymond G Flax; Dylan J Gray; Victoria N Zirimu; Ebbing de Jong; Rachel C Steinhardt
Journal:  ACS Chem Neurosci       Date:  2022-10-02       Impact factor: 5.780

2.  Affinity labeling of membrane receptors using tissue-penetrating radiations.

Authors:  Franklin C Wong; John Boja; Beng Ho; Michael J Kuhar; Dean F Wong
Journal:  Biomed Res Int       Date:  2013-06-27       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.